The risk of placental abruption is increased by cocaine abuse due to its ability to cause vasospasm in the placental blood vessels. Ceftriaxone use, which is the treatment of choice for gonorrhoeae, is not a known risk factor for placental abruption and is therefore a distractor. Although gonorrhoeae can lead to chorioamnionitis, which is a known risk factor for placental abruption, there is no evidence to suggest that this is the case and it is less likely than cocaine use. Primiparity is an incorrect answer as it is actually multiparity that is a risk factor for placental abruption.

Placental Abruption: Causes, Symptoms, and Risk Factors

Placental abruption is a condition that occurs when the placenta separates from the uterine wall, leading to maternal bleeding into the space between them. Although the exact cause of this condition is unknown, certain factors have been associated with it, including proteinuric hypertension, cocaine use, multiparity, maternal trauma, and increasing maternal age. Placental abruption is not a common occurrence, affecting approximately 1 in 200 pregnancies.

The clinical features of placental abruption include shock that is disproportionate to the visible blood loss, constant pain, a tender and tense uterus, and a normal lie and presentation of the fetus. The fetal heart may be absent or distressed, and there may be coagulation problems. It is important to be aware of other conditions that may present with similar symptoms, such as pre-eclampsia, disseminated intravascular coagulation (DIC), and anuria.

In summary, placental abruption is a serious condition that can have significant consequences for both the mother and the fetus. Understanding the risk factors and symptoms of this condition is important for early detection and appropriate management.

The recommended first line treatment for moderate to severe depression in pregnancy or post-natal period for women without a history of severe depression is a high intensity psychological intervention, such as CBT, according to the National Institute for Health and Care Excellence. If this is not accepted or symptoms do not improve, an antidepressant such as a selective serotonin re-uptake inhibitor (SSRI) or tricyclic antidepressant (TCA) should be used. Mindfulness may be helpful for women with persistent subclinical depressive symptoms. Social services should only be involved if there is a risk to someone in the household. The British National Formulary (BNF) advises against using zopiclone while breastfeeding as it is present in breast milk.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

Hormonal Changes During Pregnancy

During pregnancy, there are significant hormonal changes that occur in a woman’s body. One of the most notable changes is the increase in concentration of oestriol, which is the least potent of the three oestrogens. Oestrogen plays a crucial role in controlling other hormones such as FSH and LH, stimulating and controlling the growth of the placenta, and promoting the growth of maternal breast tissue in preparation for lactation.

Another hormone that increases during pregnancy is oestradiol, which is approximately 50-fold higher. Oestrone also increases, but oestradiol is more potent as it acts on a wider range of receptors.

On the other hand, LH and FSH are downregulated during pregnancy due to the high levels of oestrogen. The release of FSH is inhibited as follicles do not need to be stimulated during pregnancy.

Magnesium sulfate should be continued for at least 24 hours after delivery or the last seizure in the management of eclampsia. This patient’s condition has progressed to eclampsia, and the primary concern is preventing seizures and delivering the baby. Magnesium sulfate is the preferred agent for managing seizures and providing neuroprotection to the baby. Stopping magnesium sulfate immediately after the last seizure still poses a risk of another seizure occurring, so it should be continued for another 24 hours. Correcting hypertension alone is unlikely to resolve the seizures, so antihypertensive therapy should be given in addition to magnesium sulfate.

Understanding Eclampsia and its Treatment

Eclampsia is a condition that occurs when seizures develop in association with pre-eclampsia, a pregnancy-induced hypertension that is characterized by proteinuria and occurs after 20 weeks of gestation. To prevent seizures in patients with severe pre-eclampsia and treat seizures once they develop, magnesium sulphate is commonly used. However, it is important to note that this medication should only be given once a decision to deliver has been made. In cases of eclampsia, an IV bolus of 4g over 5-10 minutes should be given, followed by an infusion of 1g/hour. During treatment, it is crucial to monitor urine output, reflexes, respiratory rate, and oxygen saturations. Respiratory depression can occur, and calcium gluconate is the first-line treatment for magnesium sulphate-induced respiratory depression. Treatment should continue for 24 hours after the last seizure or delivery, as around 40% of seizures occur post-partum. Additionally, fluid restriction is necessary to avoid the potentially serious consequences of fluid overload.

In summary, understanding the development of eclampsia and its treatment is crucial in managing this potentially life-threatening condition. Magnesium sulphate is the primary medication used to prevent and treat seizures, but it should only be given once a decision to deliver has been made. Monitoring vital signs and urine output is essential during treatment, and calcium gluconate should be readily available in case of respiratory depression. Finally, fluid restriction is necessary to avoid complications associated with fluid overload.

It is recommended that pregnant women with a family history of diabetes undergo an oral glucose tolerance test (OGTT) for gestational diabetes between 24 and 28 weeks of pregnancy.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

All pregnant women who develop hypertension (systolic blood pressure over 140 mmHg or diastolic blood pressure over 90 mmHg) after 20 weeks of pregnancy should receive a secondary care assessment by a healthcare professional trained in managing hypertensive disorders of pregnancy. It is not recommended to delay this assessment by monitoring blood pressure over several days or providing lifestyle advice alone. The obstetric department may initiate antihypertensive medication and aspirin for the patient, but those with a blood pressure of 160/110 or higher are likely to be admitted for further monitoring and treatment.

Pre-eclampsia is a condition that occurs during pregnancy and is characterized by high blood pressure, proteinuria, and edema. It can lead to complications such as eclampsia, neurological issues, fetal growth problems, liver involvement, and cardiac failure. Severe pre-eclampsia is marked by hypertension, proteinuria, headache, visual disturbances, and other symptoms. Risk factors for pre-eclampsia include hypertension in a previous pregnancy, chronic kidney disease, autoimmune disease, diabetes, chronic hypertension, first pregnancy, and age over 40. Aspirin may be recommended for women with high or moderate risk factors. Treatment involves emergency assessment, admission for observation, and medication such as labetalol, nifedipine, or hydralazine. Delivery of the baby is the most important step in management, with timing depending on the individual case.

Labour is the process of giving birth and is divided into three stages. The first stage begins with regular contractions and ends when the cervix is fully dilated at 10 cm. This stage is further divided into a latent phase, where the cervix dilates to 4 cm, and an active phase, where the cervix dilates from 4 cm to 10 cm. The rate of cervical dilation in a nulliparous woman is approximately 1 cm per hour, while in a multiparous woman, it is approximately 2 cm per hour. The second stage of labour begins when the cervix is fully dilated and ends with the delivery of the baby. During this stage, fetal heart rate monitoring should occur at least every five minutes and after each contraction. Cervical incompetence, which involves cervical shortening and dilation in the absence of contractions, can result in premature delivery or second trimester loss and is more common in women with a multiple pregnancy, previous cervical incompetence, or a history of cervical surgery. These women can be managed with monitoring of cervical length, cervical cerclage, or progesterone cervical pessaries. The third stage of labour involves the delivery of the placenta and membranes.

Fetal fibronectin (fFN) is a protein that is released from the gestational sac and is associated with early labor if levels are high. However, a positive result does not guarantee premature labor. Obstetric teams can use this information to prepare for the possibility of premature labor by informing neonatal intensive care and administering steroids to aid in neonatal lung maturity. In this case, the patient is at high risk for premature labor and experiencing tightenings, so further monitoring is necessary before discharge.

Antibiotics may be necessary if the patient had spontaneously ruptured her membranes, but in this case, a history of watery discharge without fluid seen on speculum examination and a closed os is not enough to initiate antibiotic therapy. However, swabs and urine cultures should be obtained to screen for infection and treat as appropriate since infection can be a factor in premature labor.

Administering steroids can cause hyperglycemia in diabetics, so blood glucose measurements should be closely monitored. Hyperglycemia in the mother can have adverse effects on the fetus, so hourly blood glucose measurements should be taken, and additional insulin given as needed. If blood glucose levels are difficult to control, a sliding scale should be initiated according to local protocol.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Differentiating Placental Abruption from Placenta Praevia in Antepartum Haemorrhage

Antepartum haemorrhage refers to bleeding from the genital tract after 24 weeks of pregnancy but before delivery of the fetus. It is important to determine the cause of the bleeding to provide appropriate management. Two common causes of antepartum haemorrhage are placental abruption and placenta praevia.

Placental abruption is characterized by shock that is not proportional to the visible loss, constant pain, a tender and tense uterus, a normal lie and presentation, and an absent or distressed fetal heart. Coagulation problems may also be present, and healthcare providers should be cautious of pre-eclampsia, disseminated intravascular coagulation (DIC), and anuria.

On the other hand, placenta praevia is characterized by shock that is proportional to the visible loss, no pain, a uterus that is not tender, an abnormal lie and presentation, and a usually normal fetal heart. Coagulation problems are rare, and small bleeds may occur before a large one. It is important to note that vaginal examination should not be performed in primary care for suspected antepartum haemorrhage, as women with placenta praevia may experience bleeding.

In summary, distinguishing between placental abruption and placenta praevia is crucial in managing antepartum haemorrhage. Healthcare providers should carefully assess the patient’s symptoms and perform appropriate diagnostic tests to determine the cause of the bleeding.

Safe antihypertensive Medications for Pregnancy

Explanation:
When planning to get pregnant, it is important to ensure that any medications being taken are safe for the developing fetus. In the case of hypertension, switching to a safe medication prior to conception is recommended. Labetalol is the best-studied antihypertensive in pregnancy and is considered safe. Losartan, on the other hand, is contraindicated as it may affect renal development. Simply reducing the dosage of losartan is not enough to mitigate the risks of fetal maldevelopment. It is also important to maintain good blood pressure control prior to conception. Stopping antihypertensive medications abruptly is not recommended as it may lead to uncontrolled hypertension, which is associated with increased fetal loss. By taking these precautions, women can increase their chances of carrying a healthy fetus to term.

VBAC is not recommended for patients who have had previous vertical (classical) caesarean scars, experienced uterine rupture in the past, or have other contraindications to vaginal birth such as placenta praevia. However, women who have had two or more previous caesarean sections may still be considered for VBAC. The remaining options in this question do not necessarily rule out VBAC.

Caesarean Section: Types, Indications, and Risks

Caesarean section, also known as C-section, is a surgical procedure that involves delivering a baby through an incision in the mother’s abdomen and uterus. In recent years, the rate of C-section has increased significantly due to an increased fear of litigation. There are two main types of C-section: lower segment C-section, which comprises 99% of cases, and classic C-section, which involves a longitudinal incision in the upper segment of the uterus.

C-section may be indicated for various reasons, including absolute cephalopelvic disproportion, placenta praevia grades 3/4, pre-eclampsia, post-maturity, IUGR, fetal distress in labor/prolapsed cord, failure of labor to progress, malpresentations, placental abruption, vaginal infection, and cervical cancer. The urgency of C-section may be categorized into four categories, with Category 1 being the most urgent and Category 4 being elective.

It is important for clinicians to inform women of the serious and frequent risks associated with C-section, including emergency hysterectomy, need for further surgery, admission to intensive care unit, thromboembolic disease, bladder injury, ureteric injury, and death. C-section may also increase the risk of uterine rupture, antepartum stillbirth, placenta praevia, and placenta accreta in subsequent pregnancies. Other complications may include persistent wound and abdominal discomfort, increased risk of repeat C-section, readmission to hospital, haemorrhage, infection, and fetal lacerations.

Vaginal birth after C-section (VBAC) may be an appropriate method of delivery for pregnant women with a single previous C-section delivery, except for those with previous uterine rupture or classical C-section scar. The success rate of VBAC is around 70-75%.

Gestational trophoblastic disease (GTD) is a rare condition that includes hydatidiform mole, choriocarcinoma, and placental site trophoblastic tumor. GTD occurs when abnormal trophoblastic tissue forms instead of a fetus after fertilization. Hydatidiform moles are the most common form of GTD and are found in about 1 in every 1000 births. They often present with signs of early pregnancy failure, such as heavy vaginal bleeding. Treatment involves removing the abnormal tissue, and close monitoring of beta-HCG levels is necessary post-evacuation. If levels fail to drop, it may indicate an invasive mole or choriocarcinoma, which requires referral to a specialist center for further treatment. Pituitary and adrenal adenomas are other types of tumors that can produce hormones and cause various symptoms. In contrast, ectopic pregnancy is a separate condition that occurs when a fertilized egg implants outside the uterus.

Antepartum Haemorrhage: Causes and Symptoms

Antepartum haemorrhage is a condition where a pregnant woman experiences vaginal bleeding during the second half of pregnancy. There are several causes of antepartum haemorrhage, including placental abruption, concealed placental abruption, placenta accreta, placenta praevia, and premature labour.

Placental abruption is a condition where the placenta separates from the uterine lining, leading to bleeding. It can be revealed, with vaginal bleeding, or concealed, without vaginal bleeding. Risk factors for placental abruption include maternal hypertension, smoking, cocaine use, trauma, and bleeding post-procedures.

Concealed placental abruption is usually an incidental finding, with the mother recalling an episode of pain without vaginal bleeding. Placenta accreta occurs when part of the placenta grows into the myometrium, causing severe intrapartum and postpartum haemorrhage. Placenta praevia is a low-lying placenta that can cause painless vaginal bleeding and requires an elective Caesarean section. Premature labour is another common cause of antepartum bleeding associated with abdominal pain, with cyclical pain and variable vaginal bleeding.

It is important to seek medical attention if experiencing antepartum haemorrhage, as it can lead to significant maternal and fetal morbidity and mortality. Women with placenta praevia are advised to attend the Antenatal Unit for assessment and monitoring every time they have bleeding.

1. The Bishop’s score rates the cervix out of 10, with a higher score indicating a more favorable cervix and a greater likelihood of spontaneous birth. A score below 5 suggests that labor is unlikely to begin without induction.

2. This is not a reason to induce labor.

3. It is recommended that women with uncomplicated pregnancies be offered induction between 41-42 weeks to prevent the risks associated with prolonged pregnancy.

4. A previous classical Caesarean section is an absolute contraindication for inducing labor.

5. Inducing labor is not advisable when the fetus is in a breech position.

Reference: NICE guidelines – Inducing labor and Antenatal care for uncomplicated pregnancies.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

If blood glucose targets are not achieved through diet and metformin in gestational diabetes, insulin should be introduced. This patient was diagnosed with gestational diabetes at 25 weeks due to a fasting glucose level above 5.6mmol/L. Despite lifestyle changes and the addition of metformin, her glycaemic control has not improved, and her fasting glucose level remains above the target range. Therefore, NICE recommends adding short-acting insulin to her current treatment. Switching to modified-release metformin may help patients who experience side effects, but it would not improve glycaemic control in this case. Insulin should be added in conjunction with metformin for persistent impaired glycaemic control, rather than replacing it. Sulfonylureas like glibenclamide should only be used for patients who cannot tolerate metformin or as an adjunct for those who refuse insulin treatment, and they are not the best option for this patient.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

To monitor her throughout her pregnancy and postnatal period, this woman requires a referral to a perinatal mental health team due to her increased risk of postpartum psychosis. It would have been preferable for her to receive preconception advice before becoming pregnant. The recurrence rate is not influenced by the baby’s gender.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

Preterm prelabour rupture of the membranes (PPROM) is a condition that occurs in approximately 2% of pregnancies, but it is responsible for around 40% of preterm deliveries. This condition can lead to various complications, including prematurity, infection, and pulmonary hypoplasia in the fetus, as well as chorioamnionitis in the mother. To confirm PPROM, a sterile speculum examination should be performed to check for pooling of amniotic fluid in the posterior vaginal vault. However, digital examination should be avoided due to the risk of infection. If pooling of fluid is not observed, testing the fluid for placental alpha microglobulin-1 protein (PAMG-1) or insulin-like growth factor binding protein-1 is recommended. Ultrasound may also be useful to show oligohydramnios.

The management of PPROM involves admission and regular observations to ensure that chorioamnionitis is not developing. Oral erythromycin should be given for ten days, and antenatal corticosteroids should be administered to reduce the risk of respiratory distress syndrome. Delivery should be considered at 34 weeks of gestation, but there is a trade-off between an increased risk of maternal chorioamnionitis and a decreased risk of respiratory distress syndrome as the pregnancy progresses. PPROM is a serious condition that requires prompt diagnosis and management to minimize the risk of complications for both the mother and the fetus.

The patient is experiencing intense pruritus and has elevated bilirubin levels, which are common symptoms of intrahepatic cholestasis of pregnancy. Due to the heightened risk of stillbirth, induction of labor at 37 weeks is typically recommended. While a caesarian section at 37 weeks may be considered, there is insufficient evidence to support this approach over induction. Induction at 34 weeks is not advisable, and reassurance with a normal delivery at term is not appropriate. Therefore, a discussion regarding induction at 37 weeks is necessary.

Intrahepatic Cholestasis of Pregnancy: Symptoms and Management

Intrahepatic cholestasis of pregnancy, also known as obstetric cholestasis, is a condition that affects approximately 1% of pregnancies in the UK. It is characterized by intense itching, particularly on the palms, soles, and abdomen, and may also result in clinically detectable jaundice in around 20% of patients. Raised bilirubin levels are seen in over 90% of cases.

The management of intrahepatic cholestasis of pregnancy typically involves induction of labor at 37-38 weeks, although this practice may not be evidence-based. Ursodeoxycholic acid is also widely used, although the evidence base for its effectiveness is not clear. Additionally, vitamin K supplementation may be recommended.

It is important to note that the recurrence rate of intrahepatic cholestasis of pregnancy in subsequent pregnancies is high, ranging from 45-90%. Therefore, close monitoring and management are necessary for women who have experienced this condition in the past.

Pregnant women should not use novel oral anticoagulants, so those who are currently taking them should switch to low molecular weight heparin.

Venous Thromboembolism in Pregnancy: Risk Assessment and Prophylactic Measures

Pregnancy increases the risk of developing venous thromboembolism (VTE), a condition that can be life-threatening for both the mother and the fetus. To prevent VTE, it is important to assess a woman’s individual risk during pregnancy and initiate appropriate prophylactic measures. This risk assessment should be done at the first antenatal booking and on any subsequent hospital admission.

Women with a previous history of VTE are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, as well as input from experts. Women at intermediate risk due to hospitalization, surgery, co-morbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy.

If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of deep vein thrombosis (DVT) is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the treatment of choice for VTE prophylaxis in pregnancy, while direct oral anticoagulants (DOACs) and warfarin should be avoided.

In summary, a thorough risk assessment and appropriate prophylactic measures can help prevent VTE in pregnancy, which is crucial for the health and safety of both the mother and the fetus.

Treatment for Severe Pre-eclampsia and Eclampsia

The recommended treatment for severe pre-eclampsia or eclampsia is intravenous magnesium sulphate. In addition, antihypertensive treatment is also important, with labetalol being the first line of treatment for hypertension during pregnancy. Nifedipine and methyldopa also have a role to play.

Magnesium sulphate should be administered to patients with severe hypertension and proteinuria, as well as those with mild or moderate hypertension and proteinuria who exhibit symptoms such as severe headache, problems with vision, severe pain just below the ribs or vomiting, papilloedema, signs of clonus, liver tenderness, HELLP syndrome, platelet count falling to below 100 ×109/L, or abnormal liver enzymes.

The administration of magnesium sulphate involves a 4 g loading dose given intravenously over five minutes, followed by an infusion of 1 g/hr for 24 hours. In the event of recurrent seizures, an additional bolus dose of 2-4 g should be given over five minutes.

Overall, the treatment for severe pre-eclampsia and eclampsia involves a combination of intravenous magnesium sulphate and antihypertensive medication, with the dosage and administration of magnesium sulphate varying depending on the patient’s symptoms and condition.